Patents by Inventor Gary Toedter

Gary Toedter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers and Methods for Assessing and Treating Crohn's Disease and Related Disorders
    Publication number: 20140011704
    Abstract: A method for assessment of the suitability of and/or effectiveness of a target therapy for a gastrointestinal-related disorder, such as Crohn's disease, in a subject evaluates the presence, absence, and/or magnitude of expression of one or more genes in a 10-member gene panel in a sample. The method enables identification of the effectiveness of target therapies prior to or after starting a patient on such therapies.
    Type: Application
    Filed: September 18, 2013
    Publication date: January 9, 2014
    Applicant: Janssen Biotech, Inc.
    Inventors: Marion Blank, Gary Toedter
  • Markers and methods for assessing and treating Crohn's and related disorders
    Patent number: 8557745
    Abstract: A method for assessment of the suitability of and/or effectiveness of a target therapy for a gastrointestinal-related disorder, such as Crohn's disease, in a subject evaluates the presence, absence, and/or magnitude of expression of one or more genes in a 10-member gene panel in a sample. The method enables identification of the effectiveness of target therapies prior to or after starting a patient on such therapies.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: October 15, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: Marion Blank, Gary Toedter
  • MARKERS AND METHODS FOR ASSESSING AND TREATING CROHN'S DISEASE AND RELATED DISORDERS
    Publication number: 20090156418
    Abstract: A method for assessment of the suitability of and/or effectiveness of a target therapy for a gastrointestinal-related disorder, such as Crohn's disease, in a subject evaluates the presence, absence, and/or magnitude of expression of one or more genes in a 10-member gene panel in a sample. The method enables identification of the effectiveness of target therapies prior to or after starting a patient on such therapies.
    Type: Application
    Filed: May 22, 2008
    Publication date: June 18, 2009
    Inventors: Marion Blank, Gary Toedter